Literature DB >> 17250807

Interleukin-18 knockout mice display maladaptive cardiac hypertrophy in response to pressure overload.

James T Colston1, William H Boylston, Marc D Feldman, Chris P Jenkinson, Sam D de la Rosa, Amanda Barton, Rodolfo J Trevino, Gregory L Freeman, Bysani Chandrasekar.   

Abstract

Interleukin (IL)-18 is a cardiotropic proinflammatory cytokine chronically elevated in the serum of patients with cardiac hypertrophy (LVH). The purpose of this study was to examine the role of IL-18 in pressure-overload hypertrophy using wild type (WT) and IL-18 -/- (null) mice. Adult male C57Bl/6 mice underwent transaortic constriction (TAC) for 7days or sham surgery. Heart weight/body weight ratios showed blunted hypertrophy in IL-18 null TAC mice compared to WT TAC animals. Microarray analyses indicated differential expression of hypertrophy-related genes in WT versus IL-18 nulls. Northern, Western, and EMSA analyses showed Akt and GATA4 were increased in WT but unchanged in IL-18 null mice. Our results demonstrate blunted hypertrophy with reduced expression of contractile-, hypertrophy-, and remodeling-associated genes following pressure overload in IL-18 null mice, and suggest that IL-18 plays a critical role in the hypertrophic response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17250807      PMCID: PMC1847636          DOI: 10.1016/j.bbrc.2007.01.030

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

Review 1.  Inflammatory mediators and the failing heart: past, present, and the foreseeable future.

Authors:  Douglas L Mann
Journal:  Circ Res       Date:  2002-11-29       Impact factor: 17.367

2.  NetAffx: Affymetrix probesets and annotations.

Authors:  Guoying Liu; Ann E Loraine; Ron Shigeta; Melissa Cline; Jill Cheng; Venu Valmeekam; Shaw Sun; David Kulp; Michael A Siani-Rose
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

3.  Development of a multifrequency conductance catheter-based system to determine LV function in mice.

Authors:  M D Feldman; Y Mao; J W Valvano; J A Pearce; G L Freeman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-09       Impact factor: 4.733

4.  Akt/protein kinase B promotes organ growth in transgenic mice.

Authors:  Tetsuo Shioi; Julie R McMullen; Peter M Kang; Pamela S Douglas; Toshiyuki Obata; Thomas F Franke; Lewis C Cantley; Seigo Izumo
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

5.  Prognostic implications of left ventricular hypertrophy.

Authors:  B A Vakili; P M Okin; R B Devereux
Journal:  Am Heart J       Date:  2001-03       Impact factor: 4.749

6.  Effect of IL-18 on the release of IL-6 and its soluble receptors: sIL-6Ralpha and sgp130 by human neutrophils.

Authors:  E Jablonska; J Jablonski
Journal:  Immunol Invest       Date:  2002 Aug-Nov       Impact factor: 3.657

7.  Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta.

Authors:  B J Pomerantz; L L Reznikov; A H Harken; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

8.  Role of IL-18 in the secretion of Il-1beta, sIL-1RII, and IL-1Ra by human neutrophils.

Authors:  E Jablonska; A Izycka; J Jablonska; N Wawrusiewicz; J Piecuch
Journal:  Immunol Invest       Date:  2001-08       Impact factor: 3.657

9.  LV systolic performance improves with development of hypertrophy after transverse aortic constriction in mice.

Authors:  A Nakamura; D G Rokosh; M Paccanaro; R R Yee; P C Simpson; W Grossman; E Foster
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-09       Impact factor: 4.733

10.  MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data.

Authors:  Scott W Doniger; Nathan Salomonis; Kam D Dahlquist; Karen Vranizan; Steven C Lawlor; Bruce R Conklin
Journal:  Genome Biol       Date:  2003-01-06       Impact factor: 13.583

View more
  24 in total

1.  EMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-kappaB andMKK7/JNK/AP-1 signaling.

Authors:  Balachandar Venkatesan; Anthony J Valente; Sumanth D Prabhu; Prakashsrinivasan Shanmugam; Patrice Delafontaine; Bysani Chandrasekar
Journal:  J Mol Cell Cardiol       Date:  2010-06-09       Impact factor: 5.000

2.  Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy.

Authors:  Gipsy Majumdar; Robert J Rooney; I Maria Johnson; Rajendra Raghow
Journal:  Physiol Genomics       Date:  2011-09-27       Impact factor: 3.107

3.  β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.

Authors:  David R Murray; Srinivas Mummidi; Anthony J Valente; Tadashi Yoshida; Naveen K Somanna; Patrice Delafontaine; Charles A Dinarello; Bysani Chandrasekar
Journal:  J Mol Cell Cardiol       Date:  2011-10-08       Impact factor: 5.000

Review 4.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

5.  Effects of interleukin-18 on cardiac fibroblast function and gene expression.

Authors:  Charity Fix; Kellie Bingham; Wayne Carver
Journal:  Cytokine       Date:  2010-11-02       Impact factor: 3.861

6.  Interleukin 33 as a mechanically responsive cytokine secreted by living cells.

Authors:  Rahul Kakkar; Hillary Hei; Stephan Dobner; Richard T Lee
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

7.  Novel mechanisms for caspase inhibition protecting cardiac function with chronic pressure overload.

Authors:  Misun Park; Stephen F Vatner; Lin Yan; Shumin Gao; Seunghun Yoon; Grace Jung Ah Lee; Lai-Hua Xie; Richard N Kitsis; Dorothy E Vatner
Journal:  Basic Res Cardiol       Date:  2013-01-01       Impact factor: 17.165

Review 8.  Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.

Authors:  Laura C O'Brien; Eleonora Mezzaroma; Benjamin W Van Tassell; Carlo Marchetti; Salvatore Carbone; Antonio Abbate; Stefano Toldo
Journal:  Mol Med       Date:  2014-06-12       Impact factor: 6.354

9.  Ott1 (Rbm15) is essential for placental vascular branching morphogenesis and embryonic development of the heart and spleen.

Authors:  Glen D Raffel; Gerald C Chu; Jonathan L Jesneck; Dana E Cullen; Roderick T Bronson; Olivier A Bernard; D Gary Gilliland
Journal:  Mol Cell Biol       Date:  2008-11-03       Impact factor: 4.272

10.  Genetic ablation of interleukin-18 does not attenuate hypobaric hypoxia-induced right ventricular hypertrophy.

Authors:  Danielle R Bruns; Peter M Buttrick; Lori A Walker
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-08       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.